menu
    • menu
    [{"orgOrder":0,"company":"NICHD Global Network for Women's and Children's Health","sponsor":"KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India | Gates Foundation | University of Virginia | University of Alabama at Birmingham | Thomas Jefferson University | Columbia University | University of Colorado,","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Other Small Molecule","year":"2025","type":"Inapplicable","leadProduct":"Caffeine Citrate","moa":"Adenosine receptor","graph1":"Neurology","graph2":"Phase III","graph3":"NICHD Global Network for Women's and Children's Health","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Oral Solution","sponsorNew":"NICHD Global Network for Women's and Children's Health \/ KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India | Gates Foundation | University of Virginia | University of Alabama at Birmingham | Thomas Jefferson University | Columbia University | University of Colorado,","highestDevelopmentStatusID":"10","companyTruncated":"NICHD Global Network for Women's and Children's Health \/ KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India | Gates Foundation | University of Virginia | University of Alabama at Birmingham | Thomas Jefferson University | Columbia University | University of Colorado,"}]

    Find Clinical Drug Pipeline Developments & Deals for Caffeine Citrate

    Menu

    Caffeine Citrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            NICHD Global Network for Women's and Children's Health

                            Country arrow
                            EPSC
                            Not Confirmed

                            NICHD Global Network for Women's and Children's Health

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Caffeine Citrate

                            Therapeutic Area : Neurology

                            Study Phase : Phase III

                            Sponsor : KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India | Gates Foundation | University of Virginia | University of Alabama at Birmingham | Thomas Jefferson University | Columbia University | University of Colorado,

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Caffeine for Hypoxic Ischemic Encephalopathy

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            March 03, 2025

                            Lead Product(s) : Caffeine Citrate

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase III

                            Sponsor : KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India | Gates Foundation | University of Virginia | University of Alabama at Birmingham | Thomas Jefferson University | Columbia University | University of Colorado,

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Hamad Medical Corporation

                            Country arrow
                            EPSC
                            Not Confirmed

                            Hamad Medical Corporation

                            Country arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Caffeine Citrate

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Study Phase : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            September 16, 2011

                            Lead Product(s) : Caffeine Citrate

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth